中心性浆液性脉络膜视网膜病变的治疗观念亟待改变

摘要

Central serous chorioretinopathy (CSC),a self-limiting disease,is one of the most common diseases of the posterior segment.Whether therapy is necessary and how to treat CSC remain disputable.Recently,progress in photodynamic therapy (PDT) once again draws the attention of domestic ophthalmologists.This article reviews changes in the understandings of CSC pathogenesis and the changes in the treatment concept,analyzes whether CSC needs therapy,and whether PDT is more effective,economically justified and safe.%中心性浆液性脉络膜视网膜病变(简称“中浆”)是最常见的眼后段疾病之一,属临床自限性疾病,有关其是否需要治疗以及如何治疗一直存在争议.光动力疗法(PDT)治疗“中浆”的进展,再次引发了国内眼科医生的关注.现对“中浆”发病机制认识的改变以及对“中浆”治疗理念的变迁进行探讨,对“中浆”是否需要治疗、PDT治疗“中浆”是否更具有优势、经济上是否值得以及治疗安全性等问题进行评述.